利凡诺瓦

最新新闻

• 评级变动
  Needham Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $81
  \u5e02\u573a\u8d44\u8baf · 2026/2/26
• 评级变动
  KeyBanc Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $92
  \u5e02\u573a\u8d44\u8baf · 2026/6/22
• Piper Sandler Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $90
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• 评级变动
  Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $85
  \u5e02\u573a\u8d44\u8baf · 2026/4/13
• 评级变动
  Analysts' Opinions Are Mixed on These Healthcare Stocks: LivaNova (LIVN), Gain Therapeutics (GANX) and Tempus AI, Inc. Class A (TEM)
  TipRanks · 2026/7/2
• 评级变动
  Goldman Sachs Maintains LivaNova(LIVN.US) With Hold Rating, Maintains Target Price $73
  \u5e02\u573a\u8d44\u8baf · 2026/2/27
• Piper Sandler Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $87
  \u5e02\u573a\u8d44\u8baf · 2026/6/23
• 评级变动
  Stifel Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $80
  \u5e02\u573a\u8d44\u8baf · 2026/2/26
• Needham Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $93
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• 评级变动
  A Quick Look at Today's Ratings for LivaNova(LIVN.US), With a Forecast Between $72 to $90
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• 评级变动
  KeyBanc Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $81
  \u5e02\u573a\u8d44\u8baf · 2026/1/26
• 评级变动
  Baird Maintains LivaNova(LIVN.US) With Buy Rating, Cuts Target Price to $76
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• 评级变动
  Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $90
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• 评级变动
  Needham Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $81
  \u5e02\u573a\u8d44\u8baf · 2026/3/19
• 评级变动
  Barclays Maintains LivaNova(LIVN.US) With Hold Rating, Raises Target Price to $67
  \u5e02\u573a\u8d44\u8baf · 2026/1/9
• 评级变动
  Goldman Sachs Maintains LivaNova(LIVN.US) With Hold Rating, Raises Target Price to $73
  \u5e02\u573a\u8d44\u8baf · 2026/2/26
• 评级变动
  Piper Sandler Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $85
  \u5e02\u573a\u8d44\u8baf · 2026/2/19
• Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $95
  \u5e02\u573a\u8d44\u8baf · 2026/7/15
• Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/21
• 评级变动
  A Quick Look at Today's Ratings for LivaNova(LIVN.US), With a Forecast Between $73 to $85
  \u5e02\u573a\u8d44\u8baf · 2026/2/27

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。